US Neurosurgical Holding (US Neurosurgical Holding) EBIT per Share : $-0.11 (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding EBIT per Share?

US Neurosurgical Holding's EBIT per Share for the three months ended in Mar. 2024 was $-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.11.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for US Neurosurgical Holding's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of US Neurosurgical Holding was 46.30% per year. The lowest was -17.50% per year. And the median was 21.60% per year.

USNU's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

US Neurosurgical Holding's EBIT for the three months ended in Mar. 2024 was $-0.47 Mil.

US Neurosurgical Holding EBIT per Share Historical Data

The historical data trend for US Neurosurgical Holding's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding EBIT per Share Chart

US Neurosurgical Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.03

0.11

-0.07

-0.20

-0.09

US Neurosurgical Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.02	-0.03	-0.02	-0.02	-0.04

US Neurosurgical Holding EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

US Neurosurgical Holding's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.814	/	9.285
=	-0.09

US Neurosurgical Holding's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.474	/	11.899
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11

US Neurosurgical Holding (OTCPK:USNU) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

US Neurosurgical Holding EBIT per Share Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines